Below are some of the main clinical uses of CereTom:

✅ Intensive care:

Intensive care units are often faced with the challenge of transferring critically ill patients to the CT area, which in many hospitals is usually on other floors or at great distances. The problem arises when these patients are connected to various monitoring and life support equipment. In many cases, it is decided not to transfer them directly, since doing so can cause their decompensation and put them at risk.
CereTom® has the advantage of being easily mobilized by an operator and of reaching all patients, even those who cannot be transferred due to their severity. It provides the possibility of obtaining essential immediate diagnostic images at the foot of the therapy bed, without putting the patient's life at risk.

✅ Operating rooms:

Due to its portability, CereTom® can also be used inside an operating room without the need to shield the room. This allows the neurosurgeon to obtain pre-, intra-, and postoperative CT images within the same treatment room, and thus ensure the effectiveness of the procedure.

The use of CereTom® in the operating room can be applied by neurosurgery, head and neck surgery, reconstructive surgery, otorhinolaryngology, and pediatrics services, where even full-body images can be obtained.

CereTom® is compatible with all neuronavigation systems thanks to its open platform.
Some examples of the use of CereTom® in the operating room are:

-Transsphenoidal procedures.
-Tumor resections.
-Placement of ventricular catheters.
-Hematoma evacuation.
-Deep brain stimulation.
-DBS therapy.
-Aneurysms.

✅ Mobile Stroke Units

Stroke is the second cause of death and one of the main causes of disability. The impact of the medical costs associated with stroke and its disability is so great that it becomes the target of treatment and prevention strategies.

The therapeutic use of tissue plasminogen activators (tPA) had a great impact on the morbidity and mortality rates of patients with ischemic stroke, providing promising results.

The supply of thrombolytics within the first three hours is a key aspect to obtain successful results. Time is a very important factor since even 1 minute of delay in the start of treatment with tPA affects the morbidity and mortality rates.

For every minute without care, 2,000,000 neurons are lost, equivalent to 1 month of accelerated aging.

The main reason why patients do not receive tPA is the fact that they do not arrive at the hospital quickly enough to be diagnosed and treated within the treatment window.

Mobile stroke units are the technological creation to solve a growing problem worldwide.

The units consist of a CereTom mobile CT scanner mounted in an ambulance, together with a laboratory. Their configuration allows them to perform a CT scan at the patient's home, avoiding long transfer times. Obtaining images quickly allows for an immediate diagnosis along with the identification of the type of stroke.

In the case of an ischemic stroke, in 80% of cases, the patient can be given TPA inside the ambulance during the transfer to the health center. In this way, the time to treatment is reduced by 50%, generating unique results thanks to the start of treatment within the "Golden Window."